← Back to Industries
Consumer & CPG

Enterprise reasoning for consumer growth decisions

GP connects consumer signals, science, portfolio strategy, and market execution so growth teams can move from research to defensible decisions faster.

Decision infrastructure
One governed layer across the consumer growth model
Consumer signals Innovation Portfolio strategy M&A targeting Market entry
Operating Model

The decisions that shape consumer growth

GP turns fragmented consumer, scientific, portfolio, and market signals into governed recommendations that teams can act on, review, and trace back to the evidence.

01

Consumer & Market Signals

Map need states, benefit spaces, and market movement across categories.

Reasoned
02

Innovation Pipeline

Connect consumer demand to science, claims, ingredients, and formulation.

Governed
03

Portfolio & M&A Targeting

Screen markets, brands, and targets with strategic and scientific evidence.

Auditable
04

Pricing, Channel & Market Entry

Localize execution across markets, channels, consumers, and economics.

Recorded

Consumer & Market Signals

Start with the consumer. GP connects social, search, community, retail, news, and market signals across categories to identify pain points, prioritize benefits, and surface unmet needs before they become obvious.

Pain Point Identification

Multi-source analysis of consumer complaints, unmet needs, and desire paths across categories

Benefit Prioritization

Data-driven ranking of which consumer benefits matter most in each market

Global Market Signals

Cross-market intelligence identifying emerging consumer trends before they mainstream

Innovation Pipeline

GP connects consumer desire to clinical evidence, patents, ingredients, formulations, and regulatory movement so teams can prioritize new product and claims opportunities with confidence.

Clinical Trial Mining

10,000+ clinical trials and patents analyzed for new benefit space opportunities

Ingredient Intelligence

Track emerging ingredients, formulations, and delivery mechanisms across global markets

Evidence-Based Innovation

Connect R&D investment decisions to real consumer demand and competitive white space

Portfolio & M&A Targeting

GP screens hundreds of brands, companies, markets, and adjacencies against strategic fit, science, consumer demand, distribution synergies, and financial health so teams can move from long lists to defensible priorities.

300+ Companies in Days

Automated screening and scoring of potential acquisition targets at scale

Strategic Alignment

Multi-criteria evaluation: brand fit, category adjacency, distribution synergies, P&L health

Decision Trace

Preserve the evidence and tradeoffs behind each portfolio recommendation

Pricing, Channel & Market Entry

GP connects pricing decisions to consumer willingness-to-pay, competitive dynamics, channel economics, regulatory requirements, and localized market signals so execution teams can move with a defensible plan.

Community & Viral Analysis

Identify grassroots trends, micro-communities, and viral product adoption patterns

Dynamic Price Optimization

Market-aware pricing that balances volume, margin, and competitive positioning

Regulatory Mapping

Navigate product registration, ingredient restrictions, and labeling requirements by market

Deployed Workflows

Built for the decisions behind growth

Live consumer workflows where the cost of slow or fragmented analysis shows up directly in growth, margin, and strategic optionality.

Workflow: M&A Target Identification

Global Consumer Healthcare Company

A $12B+ global consumer healthcare company used GP to screen 300+ companies across clinical, commercial, and financial dimensions, reducing M&A targeting from months to days.

Challenges Addressed
Traditional M&A screening took months of manual research per cycle
Missed high-potential targets due to narrow search criteria
Difficulty connecting scientific evidence to commercial opportunity
300+
Companies analyzed
10,000+
Clinical trials processed
50%
Research time reduction
Workflow: New Product Development

Global Beverage Company

A global beverage company used GP to connect consumer desire signals, formulation intelligence, and competitive landscape analysis into a faster product and market-entry workflow.

Challenges Addressed
Fragmented consumer insight across markets and categories
Slow innovation cycles: 18+ months from insight to launch
Difficulty quantifying market opportunity for new product concepts
80%
Research time reduction
3X
Faster time-to-market
+40%
Marketing ROI improvement
Proof

Consumer growth work that moves at decision speed

Across consumer and CPG deployments, GP compresses the research cycle while preserving the reasoning trace executives need to act.

300+
Companies analyzed in days for M&A target identification
10,000+
Clinical trials and patents analyzed
50%
Reduction in M&A research time
80%
Reduction in market research time
"It's not about more data — it's about accurate decisions."
Allyn Kaufmann · Global R&D Leader, Haleon

Allyn Kaufmann, Global R&D Leader, Haleon

Get Started

See GP reason through consumer decisions

From new product development to M&A targeting, see how the enterprise reasoning platform accelerates your growth engine.

Get Started → Explore the Platform